Cargando…

BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2

BX795 is a TANK binding kinase-1 inhibitor that has shown excellent therapeutic activity in murine models of genital and ocular herpes infections on topical delivery. Currently, only the BX795 free base and its hydrochloride salt are available commercially. Here, we evaluate the ability of various o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutar, Yogesh, Yadavalli, Tejabhiram, Paul, Sagar Kumar, Mallick, Sudipta, Koganti, Raghuram, Chauhan, Harsh, Date, Abhijit A., Shukla, Deepak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623185/ https://www.ncbi.nlm.nih.gov/pubmed/34834335 http://dx.doi.org/10.3390/pharmaceutics13111920

Ejemplares similares

Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation
por: Koganti, Raghuram, et al.
Publicado: (2022)

Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction
por: Suryawanshi, Rahul K., et al.
Publicado: (2023)

BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cells
por: Su, Ai-rong, et al.
Publicado: (2017)

In vitro protocol for the optimal induction of inflammation in human monocyte cell lines
por: Koganti, Raghuram, et al.
Publicado: (2023)

Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1
por: Bhattacharya, Ilina, et al.
Publicado: (2022)

Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
por: Koganti, Raghuram, et al.
Publicado: (2019)

CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells
por: Yadavalli, Tejabhiram, et al.
Publicado: (2022)

BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
por: Chilamakuri, Rameswari, et al.
Publicado: (2021)

In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease
por: Aubert, Martine, et al.
Publicado: (2014)

OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection
por: Ames, Joshua, et al.
Publicado: (2021)

Herpes Simplex Virus Cell Entry Mechanisms: An Update
por: Madavaraju, Krishnaraju, et al.
Publicado: (2021)

Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo
por: Zabihollahi, Rezvan, et al.
Publicado: (2012)

Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017)

Vaccines and Therapies in Development for SARS-CoV-2 Infections
por: Wu, David, et al.
Publicado: (2020)

State of the Globe: Detecting HSV in Clinical Setting
por: Vanjeri, Sheetal, et al.
Publicado: (2012)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Negative epidemiological association between HSV-1 and HSV-2 infections
por: Nasrallah, Gheyath K., et al.
Publicado: (2019)

Zinc Sulfate in Narrow Range as an In Vitro Anti-HSV-1 Assay
por: Fani, Mona, et al.
Publicado: (2019)

BX795, a kinase inhibitor, inhibit duck plague virus infection via targeting US3 kinase
por: Tian, Yanming, et al.
Publicado: (2023)

HSV-1 miR-H6 Inhibits HSV-1 Replication and IL-6 Expression in Human Corneal Epithelial Cells In Vitro
por: Duan, Fang, et al.
Publicado: (2012)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

Lentiviral delivery of combinatorial CAR/CRISPRi circuit into human primary T cells is enhanced by TBK1/IKKɛ complex inhibitor BX795
por: Li, Lingyu, et al.
Publicado: (2020)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

Molecular docking analysis of a secondary metabolite with the glycoprotein receptors of HSV 1 and HSV 2
por: Saran, Natarajan, et al.
Publicado: (2019)

IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
por: Johnson, Karen E., et al.
Publicado: (2014)

An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
por: Hogk, Ina, et al.
Publicado: (2013)

Assessment of Anti HSV-1 Activity of Aloe Vera Gel Extract: an In Vitro Study
por: Rezazadeh, Fahimeh, et al.
Publicado: (2016)

Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens
por: Granato, Paul A., et al.
Publicado: (2015)

Correction: IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
por: Johnson, Karen E., et al.
Publicado: (2018)

Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties
por: Hassan, Sherif T. S., et al.
Publicado: (2019)

Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
por: Välimaa, Hannamari, et al.
Publicado: (2009)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
por: Goswami, Poorna, et al.
Publicado: (2022)

oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy
por: Sahu, Upasana, et al.
Publicado: (2023)

A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro
por: Boutell, Chris, et al.
Publicado: (2015)

Combinatorial Effects of miRNAs in HSV-2 Infection of Macrophages: An In Silico and In Vitro Integration Approach
por: Banerjee, Anwesha, et al.
Publicado: (2023)

Pathogenesis of HSV and CMV Infections in Pregnancy
por: Askienazy-Elbhar, Myriam, et al.
Publicado: (1997)

HSV Recombinant Vectors for Gene Therapy
por: Manservigi, Roberto, et al.
Publicado: (2010)

HSV-1 Cytoplasmic Envelopment and Egress
por: Ahmad, Imran, et al.
Publicado: (2020)

Oncolytic HSV: Underpinnings of Tumor Susceptibility
por: Kangas, Chase, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cg76n1oiha8mut5q4vd0b9u09l